321 related articles for article (PubMed ID: 23762257)
1. Plasma processing conditions substantially influence circulating microRNA biomarker levels.
Cheng HH; Yi HS; Kim Y; Kroh EM; Chien JW; Eaton KD; Goodman MT; Tait JF; Tewari M; Pritchard CC
PLoS One; 2013; 8(6):e64795. PubMed ID: 23762257
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as novel biomarkers for platelet activation.
Willeit P; Zampetaki A; Dudek K; Kaudewitz D; King A; Kirkby NS; Crosby-Nwaobi R; Prokopi M; Drozdov I; Langley SR; Sivaprasad S; Markus HS; Mitchell JA; Warner TD; Kiechl S; Mayr M
Circ Res; 2013 Feb; 112(4):595-600. PubMed ID: 23283721
[TBL] [Abstract][Full Text] [Related]
3. Platelets confound the measurement of extracellular miRNA in archived plasma.
Mitchell AJ; Gray WD; Hayek SS; Ko YA; Thomas S; Rooney K; Awad M; Roback JD; Quyyumi A; Searles CD
Sci Rep; 2016 Sep; 6():32651. PubMed ID: 27623086
[TBL] [Abstract][Full Text] [Related]
4. MiRNA profiles in blood plasma from mother-child duos in human biobanks and the implication of sample quality: Circulating miRNAs as potential early markers of child health.
Dypås LB; Gützkow KB; Olsen AK; Duale N
PLoS One; 2020; 15(4):e0231040. PubMed ID: 32240265
[TBL] [Abstract][Full Text] [Related]
5. Impact of Anticoagulation and Sample Processing on the Quantification of Human Blood-Derived microRNA Signatures.
Mussbacher M; Krammer TL; Heber S; Schrottmaier WC; Zeibig S; Holthoff HP; Pereyra D; Starlinger P; Hackl M; Assinger A
Cells; 2020 Aug; 9(8):. PubMed ID: 32824700
[TBL] [Abstract][Full Text] [Related]
6. Study of the preanalytical variables affecting the measurement of clinically relevant free-circulating microRNAs: focus on sample matrix, platelet depletion, and storage conditions.
Faraldi M; Sansoni V; Perego S; Gomarasca M; Kortas J; Ziemann E; Banfi G; Lombardi G
Biochem Med (Zagreb); 2020 Feb; 30(1):010703. PubMed ID: 31839723
[TBL] [Abstract][Full Text] [Related]
7. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma.
Arroyo JD; Chevillet JR; Kroh EM; Ruf IK; Pritchard CC; Gibson DF; Mitchell PS; Bennett CF; Pogosova-Agadjanyan EL; Stirewalt DL; Tait JF; Tewari M
Proc Natl Acad Sci U S A; 2011 Mar; 108(12):5003-8. PubMed ID: 21383194
[TBL] [Abstract][Full Text] [Related]
8. Potential circulating miRNA signature for early detection of NSCLC.
Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA Biomarkers and Platelet Reactivity: The Clot Thickens.
Sunderland N; Skroblin P; Barwari T; Huntley RP; Lu R; Joshi A; Lovering RC; Mayr M
Circ Res; 2017 Jan; 120(2):418-435. PubMed ID: 28104774
[TBL] [Abstract][Full Text] [Related]
10. The Influence of Pre-Analytical Factors on the Analysis of Circulating MicroRNA.
Shiotsu H; Okada K; Shibuta T; Kobayashi Y; Shirahama S; Kuroki C; Ueda S; Ohkuma M; Ikeda K; Ando Y; Matsui H; Kayamori Y; Umemura T
Microrna; 2018; 7(3):195-203. PubMed ID: 29984665
[TBL] [Abstract][Full Text] [Related]
11. Microparticles: major transport vehicles for distinct microRNAs in circulation.
Diehl P; Fricke A; Sander L; Stamm J; Bassler N; Htun N; Ziemann M; Helbing T; El-Osta A; Jowett JB; Peter K
Cardiovasc Res; 2012 Mar; 93(4):633-44. PubMed ID: 22258631
[TBL] [Abstract][Full Text] [Related]
12. Plasma microRNAs characterising patients with immune thrombocytopenic purpura.
Zuo B; Zhai J; You L; Zhao Y; Yang J; Weng Z; Dai L; Wu Q; Ruan C; He Y
Thromb Haemost; 2017 Jun; 117(7):1420-1431. PubMed ID: 28424819
[TBL] [Abstract][Full Text] [Related]
13. Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAs.
Chan SF; Cheng H; Goh KK; Zou R
J Mol Diagn; 2023 Jul; 25(7):438-453. PubMed ID: 37030398
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
15. Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations.
Glinge C; Clauss S; Boddum K; Jabbari R; Jabbari J; Risgaard B; Tomsits P; Hildebrand B; Kääb S; Wakili R; Jespersen T; Tfelt-Hansen J
PLoS One; 2017; 12(2):e0167969. PubMed ID: 28151938
[TBL] [Abstract][Full Text] [Related]
16. Assessment of circulating microRNAs in plasma of lung cancer patients.
Fortunato O; Boeri M; Verri C; Conte D; Mensah M; Suatoni P; Pastorino U; Sozzi G
Molecules; 2014 Mar; 19(3):3038-54. PubMed ID: 24619302
[TBL] [Abstract][Full Text] [Related]
17. microRNAs as promising biomarkers of platelet activity in antiplatelet therapy monitoring.
Krammer TL; Mayr M; Hackl M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423125
[TBL] [Abstract][Full Text] [Related]
18. "Future-Proofing" Blood Processing for Measurement of Circulating miRNAs in Samples from Biobanks and Prospective Clinical Trials.
Murray MJ; Watson HL; Ward D; Bailey S; Ferraresso M; Nicholson JC; Gnanapragasam VJ; Thomas B; Scarpini CG; Coleman N
Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):208-218. PubMed ID: 29254935
[No Abstract] [Full Text] [Related]
19. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-200-family micro-RNAs have altered plasma levels in patients with endometriosis and vary with blood collection time.
Rekker K; Saare M; Roost AM; Kaart T; Sõritsa D; Karro H; Sõritsa A; Simón C; Salumets A; Peters M
Fertil Steril; 2015 Oct; 104(4):938-946.e2. PubMed ID: 26206343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
